# Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

> **NCT01107327** · — · COMPLETED · sponsor: **University of Utah** · enrollment: 26 (actual)

## Conditions studied

- Venothromboembolism

## Interventions

- **PROCEDURE:** FDG-PET/CT

## Key facts

- **NCT ID:** NCT01107327
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107327, "Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01107327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*